SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-17-001631
Filing Date
2017-02-15
Accepted
2017-02-15 09:17:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G/A 171406
2 ex1.htm EX-1 11160
  Complete submission text file 0001493152-17-001631.txt   184165
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Subject) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87866 | Film No.: 17613223
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 55TH STREET 16TH FLOOR, SUITE A NEW YORK NY 10019
Business Address 250 WEST 55TH STREET 16TH FLOOR, SUITE A NEW YORK NY 10019 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A